已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study

培美曲塞 医学 耐受性 内科学 安慰剂 临床终点 危险系数 肺癌 维持疗法 外科 随机对照试验 化疗 不利影响 胃肠病学 置信区间 顺铂 替代医学 病理
作者
Tudor–Eliade Ciuleanu,Thomas Brodowicz,Christoph Zielinski,Joo Hang Kim,Maciej Krzakowski,Eckart Laack,Yi‐Long Wu,Isabel Bover,Stephen Begbie,Valentina Tzekova,Branka Čučević,José Rodrigues Pereira,Sung Hyun Yang,Jayaprakash Madhavan,Katherine P. Sugarman,Patrick Peterson,William J. John,Kurt Krejcy,Chandra P. Belani
出处
期刊:The Lancet [Elsevier]
卷期号:374 (9699): 1432-1440 被引量:1104
标识
DOI:10.1016/s0140-6736(09)61497-5
摘要

Background Several studies have shown the efficacy, tolerability, and ease of administration of pemetrexed—an antifolate antineoplastic agent—in patients with advanced non-small-cell lung cancer. We assessed pemetrexed as maintenance therapy in patients with this disease. Methods This randomised double-blind study was undertaken in 83 centres in 20 countries. 663 patients with stage IIIB or IV disease who had not progressed on four cycles of platinum-based chemotherapy were randomly assigned (2:1 ratio) to receive pemetrexed (500 mg/m2, day 1) plus best supportive care (n=441) or placebo plus best supportive care (n=222) in 21-day cycles until disease progression. Treatment was randomised with the Simon and Pocock minimisation method. Patients and investigators were masked to treatment. All patients received vitamin B12, folic acid, and dexamethasone. The primary endpoint of progression-free survival and the secondary endpoint of overall survival were analysed by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00102804. Findings All randomly assigned participants were analysed. Pemetrexed significantly improved progression-free survival (4·3 months [95% CI 4·1–4·7] vs 2·6 months [1·7–2·8]; hazard ratio [HR] 0·50, 95% CI 0·42–0·61, p<0·0001) and overall survival (13·4 months [11·9–15·9] vs 10·6 months [8·7–12·0]; HR 0·79, 0·65–0·95, p=0·012) compared with placebo. Treatment discontinuations due to drug-related toxic effects were higher in the pemetrexed group than in the placebo group (21 [5%] vs three [1%]). Drug-related grade three or higher toxic effects were higher with pemetrexed than with placebo (70 [16%] vs nine [4%]; p<0·0001), specifically fatigue (22 [5%] vs one [1%], p=0·001) and neutropenia (13 [3%] vs 0, p=0·006). No pemetrexed-related deaths occurred. Relatively fewer patients in the pemetrexed group than in the placebo group received systemic post-discontinuation therapy (227 [51%] vs 149 [67%]; p=0·0001). Interpretation Maintenance therapy with pemetrexed is well tolerated and offers improved progression-free and overall survival compared with placebo in patients with advanced non-small-cell lung cancer. Funding Eli Lilly.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
冯从露发布了新的文献求助10
刚刚
刚刚
doctor_loong完成签到,获得积分10
2秒前
orixero应助缓慢的紫伊采纳,获得10
4秒前
杨无敌完成签到 ,获得积分10
4秒前
doctor_loong发布了新的文献求助10
7秒前
Ethan完成签到 ,获得积分0
9秒前
顺心的定帮完成签到 ,获得积分10
11秒前
13秒前
mellow发布了新的文献求助10
13秒前
酷波er应助可口可乐了采纳,获得10
13秒前
露露发布了新的文献求助10
16秒前
墨与白完成签到 ,获得积分10
21秒前
hywang完成签到,获得积分10
23秒前
斯文败类应助Cloud采纳,获得10
25秒前
77完成签到 ,获得积分10
25秒前
自信号厂完成签到 ,获得积分10
29秒前
简单的尔风完成签到 ,获得积分10
29秒前
松子的ee完成签到 ,获得积分10
30秒前
六个核桃完成签到,获得积分10
30秒前
Ava应助mellow采纳,获得10
31秒前
Jasper应助TOMMY233采纳,获得10
31秒前
32秒前
Lucas应助露露采纳,获得10
33秒前
33秒前
简单的曼曼完成签到 ,获得积分10
34秒前
可爱的函函应助Joker采纳,获得10
35秒前
沐偶人发布了新的文献求助10
39秒前
40秒前
41秒前
Cloud发布了新的文献求助10
45秒前
CodeCraft应助hywang采纳,获得10
45秒前
JamesPei应助Cathy采纳,获得10
48秒前
NexusExplorer应助xv采纳,获得10
49秒前
暴躁的寻云完成签到 ,获得积分10
49秒前
49秒前
韩倩完成签到 ,获得积分10
49秒前
mellow完成签到,获得积分10
50秒前
TOMMY233发布了新的文献求助10
53秒前
55秒前
高分求助中
Evolution 10000
Sustainability in Tides Chemistry 2800
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
Foreign Policy of the French Second Empire: A Bibliography 500
Chen Hansheng: China’s Last Romantic Revolutionary 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3146623
求助须知:如何正确求助?哪些是违规求助? 2797931
关于积分的说明 7826191
捐赠科研通 2454463
什么是DOI,文献DOI怎么找? 1306280
科研通“疑难数据库(出版商)”最低求助积分说明 627692
版权声明 601522